YU45355B - Process for obtaining 6-cyclohexyl-5-(t-bocamino)-2-(2-methylpropyl)-gama-hexanolactone - Google Patents
Process for obtaining 6-cyclohexyl-5-(t-bocamino)-2-(2-methylpropyl)-gama-hexanolactoneInfo
- Publication number
- YU45355B YU45355B YU1422/86A YU142286A YU45355B YU 45355 B YU45355 B YU 45355B YU 1422/86 A YU1422/86 A YU 1422/86A YU 142286 A YU142286 A YU 142286A YU 45355 B YU45355 B YU 45355B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- sup
- chlorobenzyl
- methylpropyl
- bocamino
- hexanolactone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/86—Renin inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Pyrrole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Polyamides (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76416885A | 1985-08-09 | 1985-08-09 | |
US06/858,324 US4729985A (en) | 1985-08-09 | 1986-04-30 | Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues |
Publications (2)
Publication Number | Publication Date |
---|---|
YU142286A YU142286A (en) | 1988-10-31 |
YU45355B true YU45355B (en) | 1992-05-28 |
Family
ID=27117410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU1422/86A YU45355B (en) | 1985-08-09 | 1986-08-08 | Process for obtaining 6-cyclohexyl-5-(t-bocamino)-2-(2-methylpropyl)-gama-hexanolactone |
Country Status (22)
Country | Link |
---|---|
US (1) | US4729985A (fr) |
EP (1) | EP0212903B1 (fr) |
JP (1) | JPS6253952A (fr) |
KR (1) | KR890003603B1 (fr) |
CN (1) | CN86105870A (fr) |
AT (1) | ATE84046T1 (fr) |
AU (1) | AU576970B2 (fr) |
CA (1) | CA1294736C (fr) |
DE (1) | DE3687380T2 (fr) |
DK (1) | DK379186A (fr) |
EG (1) | EG17971A (fr) |
ES (1) | ES2000852A6 (fr) |
FI (1) | FI86192C (fr) |
GR (1) | GR862078B (fr) |
HU (1) | HU207101B (fr) |
IE (1) | IE58524B1 (fr) |
IL (1) | IL79626A0 (fr) |
NO (1) | NO170725C (fr) |
NZ (1) | NZ217127A (fr) |
PH (1) | PH24494A (fr) |
PT (1) | PT83172B (fr) |
YU (1) | YU45355B (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4727060A (en) * | 1984-11-13 | 1988-02-23 | Ciba-Geigy Corporation | Novel 5-amino-4-hydroxyvaleryl derivatives |
DE3538749A1 (de) * | 1985-10-31 | 1987-05-07 | Merck Patent Gmbh | Peptide |
FI870474A (fi) * | 1986-02-07 | 1987-08-08 | Ciba Geigy Ag | Med svavelhaltiga grupper substituerade 5-amino-4-hydroxivalerylderivat. |
DE3626130A1 (de) * | 1986-08-01 | 1988-02-11 | Merck Patent Gmbh | Aminosaeurederivate |
US4681972A (en) * | 1986-09-16 | 1987-07-21 | Warner-Lambert Company | Separation of diastereomers |
EP0264106B1 (fr) * | 1986-10-14 | 1994-03-16 | Banyu Pharmaceutical Co., Ltd. | Dérivés 5-substitués de l'acide amino-4-hydroxy-pentanoique et leur emploi |
US4927565A (en) * | 1986-12-19 | 1990-05-22 | Banyu Pharmaceutical Co., Ltd. | 5-substituted amino-4-hydroxy-pentenoic acid derivatives and their use |
US4758584A (en) * | 1987-02-05 | 1988-07-19 | Ciba-Geigy Corporation | Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups |
US4859654A (en) * | 1987-07-01 | 1989-08-22 | Pfizer Inc. | Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents |
EP0297816B1 (fr) * | 1987-07-01 | 1994-03-02 | Pfizer Inc. | Polypeptides contenant l'homocyclostatine ou la cyclostatine comme agents antihypertensifs |
EP0312158A3 (fr) * | 1987-10-13 | 1990-07-25 | Merck & Co. Inc. | Tétrapeptides ayant des composantes d'amides d'acides aminés C-terminales, inhibiteurs de la rénine |
GB8728560D0 (en) * | 1987-12-07 | 1988-01-13 | Glaxo Group Ltd | Chemical compounds |
GB8728561D0 (en) * | 1987-12-07 | 1988-01-13 | Glaxo Group Ltd | Chemical compounds |
ATE107658T1 (de) * | 1988-01-26 | 1994-07-15 | Sankyo Co | Renin inhibierende polypeptide, ihre herstellung und anwendung. |
WO1989007109A1 (fr) * | 1988-02-01 | 1989-08-10 | The Upjohn Company | Peptides inhibiteur de renine avec groupes terminaux polaires |
JPS6486550A (en) * | 1988-08-19 | 1989-03-31 | Seiko Epson Corp | Complementary mos integrated circuit |
US5436339A (en) * | 1991-03-06 | 1995-07-25 | Abbott Laboratories | Process for the preparation of a substituted diaminoalcohol |
US5238935A (en) * | 1991-05-20 | 1993-08-24 | Schering Corporation | N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme A: cholesterol acyl transferase |
US5124337A (en) * | 1991-05-20 | 1992-06-23 | Schering Corporation | N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase |
TW217410B (fr) * | 1992-04-01 | 1993-12-11 | Ciba Geigy | |
MY119161A (en) * | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
EP0702004A2 (fr) * | 1994-09-15 | 1996-03-20 | Ciba-Geigy Ag | Dérivés d'amides d'acide 2,9-diamino- et 2-amino-2-carbamoyl-4-hydroxy-alcanoiques |
EP0716077A1 (fr) * | 1994-12-08 | 1996-06-12 | Ciba-Geigy Ag | Amides d'acides oméga-amino alcanoiques et diamides alcanoiques ayant un substituant aromatique et leur application en tant qu'inhibiteurs de leur rénine |
CA2191924A1 (fr) * | 1995-12-05 | 1997-06-06 | Kevin Felsenstein | Derives de 5-amino-6-cyclohexyl-4-hydroxyhexanamide, inhibiteurs de la production de proteine .beta.-amyloide |
US5703129A (en) * | 1996-09-30 | 1997-12-30 | Bristol-Myers Squibb Company | 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production |
WO2001070672A2 (fr) | 2000-03-23 | 2001-09-27 | Elan Pharmaceuticals, Inc. | Composes et methodes de traitement de la maladie d'alzheimer |
ATE314343T1 (de) | 2000-06-30 | 2006-01-15 | Elan Pharm Inc | Verbindungen zur behandlung der alzheimerischen krankheit |
EP2464623B1 (fr) * | 2009-08-11 | 2020-11-04 | Novartis AG | Ouverture de cycle de lactones et de lactames |
CN105195868B (zh) * | 2015-11-12 | 2018-05-15 | 上海电气核电设备有限公司 | 一种机器人焊接系统及其焊接方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4163676A (en) * | 1978-04-03 | 1979-08-07 | Blue Cross Laboratories | Ethanol-modified lecithin cookware spray composition |
NO812612L (no) * | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
CA1258748A (fr) * | 1981-10-08 | 1989-08-22 | Daniel F. Veber | Peptides inhibiteurs de la renine |
US4478826A (en) * | 1981-10-08 | 1984-10-23 | Merck & Co., Inc. | Renin inhibitory peptides |
US4470971A (en) | 1981-10-19 | 1984-09-11 | Merck & Co., Inc. | Renin inhibitory peptides having His13 |
US4397786A (en) | 1981-11-23 | 1983-08-09 | Merck & Co., Inc. | Method of preparing statine and derivatives |
CA1245217A (fr) * | 1981-12-10 | 1988-11-22 | Joshua S. Boger | Peptides inhibiteurs de la renine |
EP0316965A3 (fr) * | 1983-02-07 | 1989-08-09 | Aktiebolaget Hässle | Inhibiteurs d'enzymes |
US4613676A (en) * | 1983-11-23 | 1986-09-23 | Ciba-Geigy Corporation | Substituted 5-amino-4-hydroxyvaleryl derivatives |
FI850948L (fi) * | 1984-03-12 | 1985-09-13 | Pfizer | Renin inhibitorer som innehaoller statin eller dess derivat. |
US4661473A (en) * | 1984-03-27 | 1987-04-28 | Merck & Co., Inc. | Renin inhibitors containing peptide isosteres |
FI88400C (fi) * | 1984-08-06 | 1993-05-10 | Upjohn Co | Foerfarande foer framstaellning av renin inhiberande peptider |
DE3512128A1 (de) * | 1985-04-03 | 1986-10-09 | Merck Patent Gmbh, 6100 Darmstadt | Peptide |
-
1986
- 1986-04-30 US US06/858,324 patent/US4729985A/en not_active Expired - Fee Related
- 1986-08-04 DE DE8686305995T patent/DE3687380T2/de not_active Expired - Fee Related
- 1986-08-04 EP EP86305995A patent/EP0212903B1/fr not_active Expired - Lifetime
- 1986-08-04 AT AT86305995T patent/ATE84046T1/de not_active IP Right Cessation
- 1986-08-05 IL IL79626A patent/IL79626A0/xx not_active IP Right Cessation
- 1986-08-06 GR GR862078A patent/GR862078B/el unknown
- 1986-08-07 NZ NZ217127A patent/NZ217127A/xx unknown
- 1986-08-07 PH PH34110A patent/PH24494A/en unknown
- 1986-08-07 CA CA000515464A patent/CA1294736C/fr not_active Expired - Fee Related
- 1986-08-08 KR KR1019860006535A patent/KR890003603B1/ko not_active IP Right Cessation
- 1986-08-08 FI FI863250A patent/FI86192C/fi not_active IP Right Cessation
- 1986-08-08 NO NO863202A patent/NO170725C/no unknown
- 1986-08-08 PT PT83172A patent/PT83172B/pt not_active IP Right Cessation
- 1986-08-08 IE IE214386A patent/IE58524B1/en not_active IP Right Cessation
- 1986-08-08 YU YU1422/86A patent/YU45355B/xx unknown
- 1986-08-08 ES ES8600952A patent/ES2000852A6/es not_active Expired
- 1986-08-08 HU HU863517A patent/HU207101B/hu not_active IP Right Cessation
- 1986-08-08 DK DK379186A patent/DK379186A/da not_active Application Discontinuation
- 1986-08-08 AU AU61021/86A patent/AU576970B2/en not_active Ceased
- 1986-08-09 JP JP61187653A patent/JPS6253952A/ja active Granted
- 1986-08-09 CN CN198686105870A patent/CN86105870A/zh active Pending
- 1986-08-10 EG EG503/86A patent/EG17971A/xx active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU142286A (en) | Process for obtaining 6-cyclohexyl-5-(bocamino)-2-(2-methylpropyl)-gama-hexanolactone | |
HU9300618D0 (en) | Imidazole derivatives containing biphenyl-sulfonyl-urea side chain or biphenyl-sulfonyl-urethane one as well as method for producing them and their utilization | |
EP0296581A3 (fr) | Dérivés 1,2-dicéto amino-acides comme inhibiteurs de la rénine | |
FR2575164B1 (fr) | Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant | |
KR850006941A (ko) | 데스-프로린 바조프레신 길항제의 제조방법 | |
EA200100661A1 (ru) | Способ получения производных 2-азадигидроксибицикло [2.2.1] гептана | |
HUT45518A (en) | Process for producing 1,5-benzothiazepine derivatives and pharmaceutics comprising these compounds | |
KR910009663A (ko) | 피리딘유도체, 이들을 함유하는 약리학적 조성물 및 이들의 제조방법 | |
DE3688383D1 (de) | Rekombinantes vektorsystem fuer metalloproteinase-inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren. | |
RU92004529A (ru) | Производные 2-азабицикло /2,2,1/гепт-5-ен-2-уксусной кислоты | |
ATE69806T1 (de) | Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel. | |
ATE257707T1 (de) | Verwendung von prostanoiden-antagonisten zur bhandlung von primären kopfschmerzen | |
EP0264802A3 (en) | Synthesis of peptide-aminoalkyl amides and peptide hydrazides by the solid phase method | |
SG82013A1 (en) | Process for crystallizing and collecting n3-trifluoroacetyl-basic amino acid | |
ES8801629A1 (es) | Procedimiento para preparar nuevos derivados de aminoacidos biciclicos | |
GR3027708T3 (en) | Improved process for the preparation of propargyl ammonium-chloride derivatives | |
NZ328482A (en) | Using an H2 or H3 agonist to treat sexual dysfunction | |
DE3571031D1 (en) | Antihypertensive 1,2-benzisothiazole piperidines, a method for synthesizing the same and their use as medicaments | |
JPS6419075A (en) | L-alanyl-(2alpha,3alphabeta,7alphabeta)-octahydro-1h-indole-2(s)-carboxylic acid derivative as hypotensor | |
MY101920A (en) | Antimicrobial n-(1-(alkyl or arylmethyl)-4(1h)-pyridinylidin alkanamines an acid addition salts thereof and proces for preparation, methods of use and compositions thereof |